Diagnosis of early colorectal cancer using lectin-immobilized fluorescent nanospkeres

1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Peanut agglutinin (PNA)-immobilized polystyrene nanospheres with surface poly (N-vinylacetamide) (PNVA) chains encapsulating coumarin 6 were designed as a novel colonoscopic imaging agent. PNA was atargeting moiety that binds to β3-D-galactosyl-(1-3)-N-acetyl-D-galactosamine, which is the terminal sugar of the Thomsen-Friedenreich antigen that is specifically expressed on the mucosal side of colorectal cancer cells. PNVA was immobilized with the aim of reducing nonspecific interactions between imaging agents and normal tissues. Coumarin 6 was encapsulated into nanosphere cores to provide endoscopically detectable fluorescence intensity. It is anticipated that the lectin-immobilized fluorescent nanospheres specifically accumulate on the surface of tumor tissues in the large intestine with resulting fluorescence. Real-time and accurate diagnosis of small-sized early colorectal cancer can be then achieved through observation of a clear fluorescence contrast between the normal and tumor tissues using the florescent endoscopy.

Cite

CITATION STYLE

APA

Sakuma, S., Hiwatari, K. I., Hoffman, R. M., & Yamashita, S. (2010). Diagnosis of early colorectal cancer using lectin-immobilized fluorescent nanospkeres. Drug Delivery System, 25(4), 403–410. https://doi.org/10.2745/dds.25.403

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free